Related Experiment Videos
Cost-effectiveness of statins
1Department of Endocrinology, Diabetes & Metabolism, Royal United Hospital, Bath, UK. mpsjpdr@bath.ac.uk
Current Opinion in Lipidology
|August 17, 2000
Summary
Statins effectively lower lipids and are cost-effective for preventing heart disease. However, widespread use for common risk factors may strain healthcare resources.
Area of Science:
- Cardiovascular Medicine
- Pharmacoeconomics
Background:
- Lipid-lowering therapies, particularly statins, are established interventions for cardiovascular disease.
- Statins have demonstrated efficacy in both secondary and primary prevention of coronary heart disease.
- Cost-effectiveness analyses support statin use in managing cardiovascular risk.
Purpose of the Study:
- To evaluate the economic implications of widespread statin use.
- To assess the impact of targeting high-risk groups for cardiovascular disease prevention.
Main Methods:
- Review of indirect estimations and long-term randomized trials.
- Analysis of cost-effectiveness in primary and secondary prevention.
- Consideration of absolute risk calculation for targeted care.
Main Results:
- Statin therapy is proven effective and cost-effective for coronary heart disease prevention.
- Efficient care targeting high-risk individuals is crucial.
- The high prevalence of coronary heart disease and risk factors poses a significant challenge to healthcare resources.
Conclusions:
- While statins are effective and cost-effective, their broad application necessitates careful resource allocation.
- Managing cardiovascular disease requires balancing intervention efficacy with healthcare system capacity.